Effects of an Extract of the Brown Seaweed Ascophylum nodosum on Postprandial Glycaemic Control in Healthy Subjects: A Randomized Controlled Study

Author:

Konic Ristic Aleksandra12ORCID,Ryan Sinead3,Attjioui Maha3,O’Connell Shane34,Gibney Eileen R.12ORCID

Affiliation:

1. UCD School of Agriculture and Food Science, University College Dublin, D04V1W8 Belfiled, Dublin, Ireland

2. UCD Institute of Food and Health, University College Dublin, D04V1W8 Belfield, Dublin, Ireland

3. Marigot Ltd., P43NN62 Carrigaline, Ireland

4. Shannon Applied Biotechnology Centre, Munster Technological University-Kerry, V92CX88 Tralee, Ireland

Abstract

The effects of the consumption of an extract of the brown seaweed Ascophyllum nodosum (BSW) on postprandial glucose and insulin responses to white bread were investigated in an acute, randomized, double-blind, three-arm, crossover, controlled trial in healthy, normoglycemic subjects. Sixteen subjects were administered either control white bread (50 g total digestible carbohydrates) or white bread with 500 mg or 1000 mg of BSW extract. Biochemical parameters were measured in venous blood over 3 h. Significant inter-individual variation in the glycaemic response to white bread was observed. Analysis of the responses of all subjects to either 500 mg or 1000 mg of BSW extract versus control revealed no significant effects of treatments. The variation in response to the control was used to classify individuals into glycaemic responders and non-responders. In the sub-cohort of 10 subjects with peak glucose levels after white bread above 1 mmol/L, we observed a significant decrease in maximum levels of plasma glucose after the intervention meal with 1000 mg of extract compared with the control. No adverse effects were reported. Further work is warranted to define all factors that determine “responders” to the effects of brown seaweed extracts and identify the cohort that would benefit the most from their consumption.

Funder

European Union’s Horizon 2020 research and innovation programme

Publisher

MDPI AG

Subject

Drug Discovery,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmaceutical Science

Reference59 articles.

1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition;Saeedi;Diabetes Res. Clin. Pract.,2019

2. Epidemiology of cardiovascular disease in Europe;Townsend;Nat. Rev. Cardiol.,2022

3. Mortality attributable to diabetes in 20–79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition;Saeedi;Diabetes Res. Clin. Pract.,2020

4. Is nutrition science ready for the twenty-first century? Moving towards transdisciplinary impacts in a changing world;Tufford;Eur. J. Nutr.,2020

5. FAO, IFAD, UNICEF, WFP, and WHO (2021). The State of Food Security and Nutrition in the World 2021, FAO. Transforming Food Systems for Food Security, Improved Nutrition and Affordable Healthy Diets for All.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3